GeneDx Holdings Corp.
WGS- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001818331
In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 223 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding GeneDx Holdings Corp. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 86 | 1 | 136 | +51 |
| Shares | 16.3M | 924.6K | 18.8M | +3.47M (+22.6%) |
| Value | $425.7M | $24.2M | $799.5M | +$398.0M (+99.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (57)
Institutions that held GeneDx Holdings Corp. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (6)
Institutions that held GeneDx Holdings Corp. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Soleus Capital Management, L.P. | 87,000 | $2.27M |
| Alpine Global Management, LLC | 11,878 | $310.5K |
| Pura Vida Investments, LLC | 10,000 | $261.4K |
| Raymond James Financial Services Advisors, Inc. | 8,609 | $225.0K |
| nVerses Capital, LLC | 1,900 | $49.7K |
| Cornerstone Planning Group LLC | 16 | $451 |
Not filed for Q3 2024 yet (1)
Institutions that held GeneDx Holdings Corp. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 924,569 | $24.2M |